Immune checkpoint inhibitor‐mediated psoriasis treated with biologics
Abstract Skin toxicities are the most prevalent immune‐related adverse events of immune checkpoint inhibitors (ICIs), but psoriasis is uncommon. To date, there are no treatment guidelines for this unique patient cohort. We describe a case of ICI‐mediated psoriasis and its treatment using a tumour ne...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Wiley,
2023-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |